A decrease in plasma Ca2+ and increases in plasma immunoreactive parathyroid hormone (PTH) have been reported in spontaneously hypertensive (SH) rats as compared with normotensive Wistar-Kyoto (WKy) rats. These changes should lead to a higher plasma 1,25(OH)2D (1,25-dihydroxycholecalciferol/ 1,25-dihydroxyergocalciferol) concentration in St1 rat if the kidney responds appropriately. Plasma 1,25(OH)2D, however, has been reported to be normal in SH rats, suggesting possible impairments of vitamin D metabolism in this animal model of hypertension. To test this possibility, we studied the effect of PTH on renal production of 1,25(OH)2D in SH rats before (4 weeks of age) and after (12 weeks of age) the onset of hypertension. Basal serum levels of 1,25(OH)2D were normal in SH rats at both ages. At 4 weeks of age, the rise in serum 1,25(OH)2D after PTH injection (50 units subcutaneously every 2 h; four times) was also normal in SH rats. By contrast, at 12 weeks of age, the rise in serum 1,25(OH)2D was approximately one-half of that in WKy rats, despite the similar rises in serum Ca2+ levels in both groups by PTH injection. The attenuated rise in serum 1 ,25(OH)2D in SH rats was consistent with the impaired response of renal 1-hydroxylase (25-hydroxycholecalciferol la-hydroxylase) activity to PTH. Basal 1,25(OH)2D production by the kidney in SH rat was higher than that in WKy rats both at 4 and 12 weeks of age. These data suggest that, in SH rats: (1) serum 1,25(OH)2D is inappropriately low in relation to the elevated PTH and this may be due, at least in part, to the impaired responsiveness to PTH of renal 1-hydroxylase and to the enhanced metabolism of 1,25(OH)2D, and (2) elevated PTH or other agents may stimulate the 1-hydroxylase in the kidney even before the onset of hypertension.
INTRODUCTION
Accumulating evidence suggests that calcium homoeostasis has a significant role in the development and maintenance of hypertension. Dietary calcium intake is lower in patients with hypertension than in normotensive individuals (Belizan & Villar, 1980) . In epidemiological studies, low dietary calcium has been associated with hypertension (Neri et al., 1972; Masironi et al., 1976) . Low calcium intake increases blood pressure in WKy rats (McCarron, 1982a) , which are controls for SH rats developed from this strain. High calcium intake lowers blood presure in SH rats (Ayachi, 1979; McCarron et al., 1981; Chen et al., 1982; Schneiderman et al., 1984) as well as in WKy rats (Ayachi, 1979; Schneiderman et al., 1984) .
Total serum calcium is similar in patients with essential hypertension and in normotensive controls, but serum ionized calcium (Ca2+) is decreased in hypertensive patients (McCarron, 1982b) . This is also true in SH rats as compared with WKy rats; under comparable feeding conditions, serum Ca2+ is lower in SH rats than in WKy rats (McCarron et al., 1981; Wright et al., 1980; Wright & Rankin, 1982) . Serum immunoreactive PTH is elevated in patients with essential hypertension (McCarron et al., 1980) and in SH rats (McCarron et al., 1981) . Intestinal Ca2+ absorption is decreased (Schedl et al., 1984) , unchanged (Stern et al., 1984) or less responsive to exogenous 1,25(OH)2D3 (Toraason & Wright, 1981) in SH rats. Plasma 25(OH)D3 is lower in patients with hypertension treated with hydrochlorothiazide (Kokot et al., 1981) and higher in SH rats than in WKy rats (Schedl et al., 1984) , whereas plasma 1,25(OH)2D3 is reported to be normal in SH rats at 12 weeks of age (Schedl et al., 1984; Stern et al., 1984 (Connerty & Briggs, 1966) . Blood pressure was monitored with an electrosphygmomanometer (Narco Biosystem, Houston, TX, U.S.A.) on the day before the experiment.
To examine renal function, creatinine clearance was measured in another set of experiments. Animals were anaesthetized with sodium pentobarbital (40 mg/kg, intraperitoneally) and were infused via a femoral arterial catheter at a rate of 1 ml/h with a solution composed of 5 mM-CaCl2, 5 mM-MgCl2, 20 mM-NaCl, 2.5 mM-KCl and 4% (w/v) Production of 1,25(OH)2D by the kidney Mitochondria were prepared from the kidney, and incubations were performed by the method of Vieth & Fraser (1979) . The kidneys were placed in an ice-cold homogenization medium (250 mM-sucrose/10 mMHepes/10 mM-KCl, adjusted with NaOH to pH 7.42 at room temperature) and cortical tissues were obtained after removing capsules, papilla, ureter and medulla. The tissues were homogenized in 10 vol. (w/v) of ice-cold homogenization medium with a motor-driven PotterElvehjem homogenizer. The homogenate was centrifuged at 4000 g and 4°C for 40 s, and the supernatant was centrifuged at 9000 g and 4°C for 20 min. The pellet was suspended in 10-15 vol. of ice-cold incubation medium (125 mM-KCl/20 mM-Hepes/10 mM-L-malic acid/2 mmMgSO3/1 mM-dithiothreitol/0.25 mM-EDTA, adjusted to pH 7.42 at room temperature; the final concentration of mitochondrial protein was 2.5-5 mg/ml. Each incubation sample consisted of a 1.0 ml portion of mitochondrial suspension. Samples, in 25 ml Erlenmeyer flasks, were placed in a Dubnoff incubator at 25°C, shaking at 100 cycles/min. At 3 min, 5,tg of 25(OH)D3 (kindly provided by the Upjohn Co., Kalamazoo, MI, U.S.A.) in 20 ,ul of ethanol were added. After substrate addition, the flask was gassed for 1 min with a direct flow of 02/C02 (19: 1) at a rate of 0.5 litre/min. Immediately after gassing, the flask was sealed with a rubber stopper, incubated at 25°C for 15 min and the reaction was stopped by the addition of 3.75 ml of methanol/ chloroform (2: 1, v/v).
Determination of 1,25(OH)2D
Lipid extraction was performed by the method of Bligh & Dyer (1959) . The extract was dried under an N2
gas stream and resolved in n-hexane/methanol/chloroform (9: 1: 1, by vol.), and then subjected to. Sephadex LH-20 column chromatography. The column was eluted with the same solvent at a rate of 0.6 ml/min, and fractions (3 ml each) were collected. Fractions (nos. 63-74) containing 1,25(OH)2D were pooled, dried under an N2 gas stream and resolved in n-hexane and propan-2-ol (9: 1, v/v), and subjected to h.p. The tubes were vortex-mixed and the incubation was continued for 15 min in a 25°C water bath with shaking. The tubes were allowed to cool for 5 min in an ice bath, and 200 1l of dextran-coated charcoal suspension were added to each tube, followed by vortex-mixing. The tube contents were vortex-mixed again after 10 min and, after 2 min ofcharcoal treatment, bound and free hormones were separated by centrifugation at 2000 g for 10 min. The supernatant containing bound hormones was decanted into a scintillation vial and radioactivity was determined in a liquid-scintillation counter (Beckman; model 8100) (counting efficiency approx. 40%).
Protein determination
The mitochondrial protein concentration was measured by the method of Lowry et al. (1951) , with bovine serum albumin as standard.
Calculations
The 1,25(OH)2D value (pg/tube) was calculated by using a logit-log plot of the data. The 1,25(OH)2D concentration of serum (pg/ml) or 1,25(OH)2D production by tissues (fmol/mg of protein) were obtained after correcting for recovery (approx. 50%) and sample volume.
Statistical analysis
ReXVsults are given as + S.E.M. and statistical analysis was performed by Student's t test.
Vitamin D metabolism in the spontaneously hypertensive rat (Fig. 1) . On the basis of these data and the fact Table 3 . Creatinine clearance in SH and WKy rats at 12 weeks of age Rats were treated as described in Table 2 and anaesthetized with sodium pentobarbital. Rats were infused at a rate of 1 ml/h with a solution composed of 5 mM-CaCl2, 5 mM-MgCl2, 20 mM-NaCl, 2.5 mM-KCI and 4% (w/v) glucose, starting at 5 h. Urine was collected from 6 to 8 h via a catheter inserted into the bladder. Serum samples were obtained via a catheter inserted through the femoral vein. Abbreviation used: n.s., not significant. (Fig. 1 ).
As Table 3 shows, no difference in the creatinine clearance was observed between SH and WKy rats at 12 weeks of age.
DISCUSSION
The present study supports the previous observations by others (Shedl et al., 1984; Stern et al., 1984) (Fig. 1) . By contrast, that from SH rats at 12 weeks of age showed a markedly reduced response, suggesting that the decreased serum 1,25(OH)2D in response to PTH injection may be mainly due to the impaired response to PTH of 1-hydroxylase (Fig. 1) .
Although normal renal function has been reported for SH rats as compared with age-matched WKy rats, it is possible that the observed reduction in response to PTH of -hydroxylase in SH rats at 12 weeks in the present study may have been a result of reduced renal function. It turned out not to be the case, however, since creatinine clearance in SH rats at this age did not differ from that in WKy rats (Table 3) . Thus the attenuated response to PTH of 1-hydroxylase seems to be attributable to the decreased responsiveness ofthe enzyme activity itself. Two possible mechanisms may account for the attenuated responsiveness of the enzyme activity to PTH. One is that, with existing high levels of PTH in the SH rats, the renal 1-hydroxylase is incapable of further substantial increase in activity. This may be partly true, since basal 1,25(OH)2D production by the kidney was higher in the SH rats as compared with that in WKy rats (Fig. 1) , a finding that is consistent with the reported hyperparathyroidism. However, since PTH has been known to inhibit phosphate reabsorption in the renal proximal convoluted tubules where 60-70% of filtered load of phosphate is reabsorbed, and since the phosphaturic effect of PTH was greater in SH rats than in WKy rats (670+85mg/100ml of urine as against 432+69mg/ 100 ml of urine) in the present study, it is unlikely that the inhibitory effect of PTH on the reabsorption of phosphate in this nephron segment is impaired in SH rats. It is well established that PTH activates the adenylate cyclase system through binding to its receptor in the proximal convoluted tubules, which, in turn, leads to the inhibition of phosphate reabsorption as well as to the stimulation of 1-hydroxylase. Taken together, the attenuated response of 1 -hydroxylase to PTH in SH rats observed in the present study could not be explained by a simple down-regulation of receptor due to the existence of higher PTH levels. Another possibility is that the SH rat may have a general defect in the transport of cell calcium that itself could result in secondary impairment of the control of the 1-hydroxylase. Decreases in urinary calcium excretion after PTH injection were, however, in the same range in SH and WKy rats (5.1 + 0.6 and 3.8 + 0.5 mg/ml respectively), thus suggesting that cellular calcium transport in the kidney of SH rat remains intact, although the possibility that the intracellular calcium concentration remains higher in SH rats is not ruled out.
No data are available on serum PTH in SH rats at 4 weeks of age. However, as shown in Fig. 1 , basal 1,25(OH)2D production by the kidney from SH rats was higher than that in WKy rats. These data suggest hyperparathyroidism or the presence of agents that stimulate the renal 1-hydroxylase activity in SH rats even at 4 weeks of age, when blood pressure is normal. Similar serum 1,25(OH)2D levels in SH and WKy rats, notwithstandingthehigherbasal 1,25(OH)2D3production by the kidney in SH rats (Fig. 1) , suggest possible enhancement of metabolism and/or excretion of 1,25(OH)2D.
These data suggest that abnormality of calcium metabolism and, in particular, vitamin D metabolism, may contribute to the development of hypertension. Elucidation of (1) the mechanism underlying the effect of age on the impaired response to PTH of renal 1-hydroxylase and (2) the cause of higher basal enzyme activity even before the onset of hypertension, as well as the cause of enhanced metabolism of 1,25(OH)2D, may provide further insight into pathophysiology of hypertension. 
